SCHEMBL8329957

SCHEMBL8329957

C=CCC(CNC)c1cccc(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 10/20 0.44
SLC6A2 P23975 9/20 0.44
TAAR1 Q96RJ0 1/20 0.38
ADRB2 P07550 2/20 0.36
ADRB1 P08588 2/20 0.36
ADRB3 P13945 2/20 0.36
SLC6A3 Q01959 7/20 0.36
HIF1A Q16665 2/20 0.36
HTR1A P08908 1/20 0.36
ADRA2A P08913 1/20 0.36
TSHR P16473 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
NFKB1 P19838 1/20 0.36
DRD1 P21728 1/20 0.36
HTR7 P34969 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36
DRD3 P35462 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8045114 1.00 SLC6A4 (0.44) SLC6A4SLC6A2TAAR1ADRB2ADRB1
Methylamine SCHEMBL8583464 0.96 SLC6A4 (0.41) SLC6A4SLC6A2TAAR1ADRB2ADRB1
SCHEMBL22728188 0.81 ATM (0.44) SLC6A4SLC6A2TAAR1ADRB2SLC6A3
SCHEMBL10366932 0.81 ACP3 (0.39) SLC6A4SLC6A2TSHR
SCHEMBL8031389 0.80 TAAR1 (0.48) SLC6A4SLC6A2TAAR1SLC6A3CYP2D6
SCHEMBL6422129 0.80 TAAR1 (0.48) SLC6A4SLC6A2TAAR1SLC6A3CYP2D6
SCHEMBL6421394 0.80 TAAR1 (0.48) SLC6A4SLC6A2TAAR1SLC6A3CYP2D6
SCHEMBL6424065 0.80 SLC6A2 (0.51) SLC6A4SLC6A2SLC6A3CYP2D6KCNH2
SCHEMBL6424063 0.80 SLC6A2 (0.51) SLC6A4SLC6A2SLC6A3CYP2D6KCNH2
SCHEMBL11075225 0.80 SLC6A4 (0.47) SLC6A4SLC6A2TAAR1ADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5962462-A COMPOUNDS WHICH INHIBIT THE ENTRY OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTO TARGET CELLS; DELAYING THE ONSET OF ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS). MERCK & CO., INC. (US) 1999-10-05 US disclosed
WO-1998025605-A1 SPIRO-SUBSTITUTED AZACYCLES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 1998-06-18 WO disclosed